ArticleThe international journal of medical robotics + computer assisted surgery : MRCAS2025
Functional Outcomes After 'SHURUI' Single-Port Robot-Assisted Pyeloplasty for Uretero Pelvic Junction Obstruction: Single-Centre Experience.
Article in The international journal of medical robotics + computer assisted surgery : MRCAS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Single-incision robotic versus laparoscopic cholecystectomy: initial experience with the EDGE SP1000 robotic system at a Shanghai center.Surgical endoscopy · 2026Article
- First report of transumbilical robotic-assisted single-port laparoscopic partial nephrectomy using a domestic ShuruiTranslational andrology and urology · 2026Article
- Safety and Efficacy of SHURUI Single-Port Serpentine-Arm Robotic Surgery System in Lung Surgery: A Prospective Single-Centre Study.Interdisciplinary cardiovascular and thoracic surgery · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTo explore the preliminary safety and efficacy of domestic single-port robot-assisted pyeloplasty in ureteropelvic junction obstruction.
methodsData from patients undergoing single-port robotic-assisted pyeloplasty (November 2023-May 2024) using the 'SHURUI' SP system through a single-site approach were reviewed. Details included patient demographics, intraoperative and postoperative data, and surgical outcomes.
resultsThe study included 20 patients, ages 13-39, with a male-to-female ratio of 4:1. CLINICAL PRESENTATIONS: abdominal pain (7cases), infection (2cases), and asymptomatic (11cases). All surgeries were successful, with an average operation time of 147(IQR, 125-175) minutes, blood loss of 35(IQR, 30-60) mL, and a hospital stay of 5(IQR, 3-6)days. The ureteral stent was removed 6-8 weeks post-surgery, with a subsequent CT scan at 4 months showing 100% success based on pain and obstruction resolution.
conclusionThe 'SHURUI' single-port robotic-assisted pyeloplasty is a safe and feasible treatment for UPJO in both adults and paediatric patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.